Mylan Pharmaceuticals Inc. v. Pfizer Inc. > Summary
Court Case Number IPR2018-00892
Filing Date Apr 5, 2018
Institution Decision Date Oct 15, 2018
Decision Date Jan 16, 2019
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesSheridan K. Snedden, Zhenyu Yang, Kristi L. R. Sawert
Judge Writing the Final DecisionSheridan K. Snedden
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
Petitioner
Petitioner Attorneys
5Viatris Inc.
Attorney Name: Robert L. Florence
Parker Poe Adams & Bernstein LLP
Viatris Inc.
Attorney Name: Michael L. Binns
Parker Poe Adams & Bernstein LLP
Viatris Inc.
Attorney Name: Karen L. Carroll
Parker Poe Adams & Bernstein LLP
Viatris Inc.
Attorney Name: Kinam Park
Purdue University
Patent Owner Attorneys
7Pfizer
Attorney Name: Michael E. Nelson
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Kevin M. Yurkerwich
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Timothy A. Cook
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Heather M. Petruzzi
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Kevin S. Prussia
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Amy K. Wigmore
Wilmer Cutler Pickering Hale and Dorr
Pfizer
Attorney Name: Jason M. Okun
Venable
Related Patents
Doc No | Title | Issue date |
---|---|---|
09326945 | Apixaban formulations | May 3, 2016 |